A world class team brimming with
expertise, passion and talent

Aurelija’s work at P4A includes overseeing all accounting activities from managing financial risk to setting the budgets. Also, to ensure the smooth day to day finance operations within the business.​

​

Aurelija is a Chartered Accountant, with 10+ years of experience, she holds MSc in Financial Economics from the University of Exeter and BSc in the same field. ​

​

Prior to P4A she worked for the small start-ups as well as big listed companies in healthcare, consulting and property industries. She is a problem solver with the ability to adapt well to new situations as well as review and improve the internal controls within the organisation.’

Darren has >10 years’ experience in market access and digital health consultancy; his main role at P4A is identifying and developing innovative solutions for the market access and launch readiness challenges our customers face. Darren has a deep understanding of healthcare markets across Europe and amassed extensive experience with multi-stakeholder collaborations driving positive, sustainable, and innovative improvements to healthcare.

Prior to P4A, he worked at S3 Connected Health and Dolon, allowing him to develop expertise in market access and commercial strategy along with digital solution design for pharma and medtech.

Darren has a BSc in Physiology, MSc in Biotechnology and Business Management from The University of Warwick and Prof Dip in Business Finance from Smurfit Business School. In his spare time, he enjoys playing and coaching basketball and hurling.

Rosa is a Director at Partners4Access, bringing 7 years of experience in market access consulting, with a particular focus over the last 5 years on rare diseases and cell therapies. She has a strong background in payer value strategy and communication, pricing & reimbursement (P&R) strategy, and launch preparations, working across several therapeutic areas, including oncology and metabolic diseases. Rosa has extensive experience in large and small European markets, as well as emerging markets such as Brazil and the Middle East.

Before joining Partners4Access, Rosa held roles at Dolon and Huron/Pope Woodhead, where she honed her expertise in market access and strategy development.

Rosa holds a PhD in Genetics and Developmental Biology from University College London and a Master’s in Human Molecular Genetics from Imperial College London.

Josh’s role at Partners4Access includes conducting primary and secondary research to support the development of market access and reimbursement strategies for clients in the pharmaceutical and biotechnology industries.

Josh has prior experience in MedComms consulting, where he primarily worked on market access focused projects across the pharmaceutical and MedTech sectors. His experience during this time ranged from writing HTA submissions to conducting market landscaping assessments. He has a strong interest in the pricing, reimbursement and market access challenges encountered in rare diseases, and is highly motivated to support pharmaceutical and biotech clients in overcoming these challenges to bring new therapies to patients.

Josh holds an M.Sc. and B.Sc. in Neuroscience from University College London. His M.Sc. research involved using electrophysiological methods to explore how the protein structure of glutamate neurotransmitter receptors influenced their function in synaptic transmission.

Sebastian recently graduated from University of Bath in 2024 with an MSc in Data Science where he focused on machine learning, deep learning and reinforcement learning. Before that Sebastian studied Mathematics with Economics at Loughborough University for his undergraduate degree, which allowed him to synthesis theoretical understanding from Mathematics and applied solutions with programming. Sebastian is currently focused on natural language processing, data analytics and statistical modeling.

Will is an Analyst at Partners4Access, where he conducts in-depth primary and secondary research to address market access and reimbursement challenges for clients in the biotechnology and pharmaceutical industries.

He is driven by a commitment to improving patient access to crucial medications, aiming to enhance the quality of life for those in need.v Before joining Partners4Access, Will completed an MPhil in Clinical Medicine at the University of Cambridge. His research focused on enhancing insulin sensitivity as a pathway to developing innovative treatments for type 2 diabetes.

Will also holds a BSc in Molecular Biology and Genetics from the University of East Anglia, and his academic background underpins his dedication to bridging scientific advancements with better healthcare accessibility.

Thea’s role at Partners4Access includes conducting primary and secondary research to assist in the development of market access and reimbursement strategies for biotechnology and pharmaceutical companies.

Thea holds a Master’s degree in Stem Cells and Regenerative Medicine: From Bench to Market from King’s College London. Her studies inspired a passion for cell and gene therapies and her thesis focused on the potential of using iPSC-derived CAR macrophage cells to target metastatic renal cell carcinoma. This gave her the opportunity to explore the commercialisation and reimbursement of cell therapies. She previously studied Biomedical Sciences at the University of Bristol. Prior to joining P4A, Thea completed an internship in the market access team at a pharmaceutical company who specialise in orphan drugs, where she learned more about the rare disease landscape.

Keenan plays a key role in conducting research and analysis to support the development of market access and reimbursement strategies for pharmaceutical and biotechnology clients. Keenan is a GPhC-registered Pharmacist with an MPharm degree from University College London. He brings over 5 years of experience in managing clinical pharmacy services and pharmaceutical operations across both the NHS and private sectors. With his clinical expertise, Keenan is particularly driven to improve treatment access for patients with rare diseases.

Away from work Keenan iss a huge tennis fan and attend Wimbledon every year. Over the years he has mastered the art of queueing – almost as competitive as the matches themselves

Patrick plays a key role in conducting both primary and secondary research and analysis to support the development of market access and reimbursement strategies for pharmaceutical and biotechnology clients.

He holds a PhD in Cancer Biology with a focus on Immuno-oncology from the University of Liverpool, where his research explored the role of tumour-associated macrophages and cancer-associated fibroblasts in regulating CD8+ T cell recruitment in pancreatic cancer.

Patrick also brings experience from the life sciences consulting sector, having worked with several boutique consultancies on a contract basis both during and after completion of his PhD. In these roles, he supported a range of strategic projects, producing evidence-based slide decks and value stories derived from his analysis of NHS datasets, with a particular focus on rare diseases.

With a strong scientific foundation and a passion for patient-centred innovation, Patrick is especially motivated to improve access to treatments for patients with rare diseases and urgent unmet clinical needs.